Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 38(19): 3681-3695, 2019 05.
Article in English | MEDLINE | ID: mdl-30664688

ABSTRACT

Leukocyte infiltration plays an active role in controlling tumor development. In the early stages of carcinogenesis, T cells counteract tumor growth. However, in advanced stages, cancer cells and infiltrating stromal components interfere with the immune control and instruct immune cells to support, rather than counteract, tumor malignancy, via cell-cell contact or soluble mediators. In particular, metabolites are emerging as active players in driving immunosuppression. Here we demonstrate that in a prostate cancer model lactate released by glycolytic cancer-associated fibroblasts (CAFs) acts on CD4+ T cells, shaping T-cell polarization. In particular, CAFs exposure (i) reduces the percentage of the antitumoral Th1 subset, inducing a lactate-dependent, SIRT1-mediated deacetylation/degradation of T-bet transcription factor; (ii) increases Treg cells, driving naive T cells polarization, through a lactate-based NF-kB activation and FoxP3 expression. In turn, this metabolic-based CAF-immunomodulated environment exerts a pro-invasive effect on prostate cancer cells, by activating a previously unexplored miR21/TLR8 axis that sustains cancer malignancy.


Subject(s)
CD4-Positive T-Lymphocytes/pathology , Lactic Acid/metabolism , MicroRNAs/metabolism , Toll-Like Receptor 8/metabolism , Tumor Microenvironment/immunology , Acetylation , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Cancer-Associated Fibroblasts/metabolism , Cancer-Associated Fibroblasts/pathology , Forkhead Transcription Factors/metabolism , Humans , Immune Tolerance , Male , NF-kappa B/metabolism , Prostatic Neoplasms/immunology , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Sirtuin 1/metabolism , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology , Th1 Cells/immunology , Th1 Cells/metabolism , Th1 Cells/pathology , Toll-Like Receptor 8/genetics , Toll-Like Receptor 8/immunology
2.
Biomed Res Int ; 2014: 486798, 2014.
Article in English | MEDLINE | ID: mdl-24738060

ABSTRACT

INTRODUCTION: The aim of our work was to investigate the causal connection between M1 and M2 macrophage phenotypes occurrence and prostate cancer, their correlation with tumor extension (ECE), and biochemical recurrence (BR). PATIENT AND METHODS: Clinical and pathological data were prospectively gathered from 93 patients treated with radical prostatectomy. Correlations of commonly used variables were evaluated with uni- and multivariate analysis. The relationship between M1 and M2 occurrence and BR was also assessed with Kaplan-Meier survival analysis. RESULTS: Above all in 63.4% there was a M2 prevalence. M1 occurred more frequently in OC disease, while M2 was more represented in ECE. At univariate analysis biopsy and pathologic GS and M2 were statistically correlated with ECE. Only pathologic GS and M2 confirmed to be correlated with ECE. According to macrophage density BCR free survival curves presented a statistically significant difference. When we stratified our population for M1 and M2,we did not find any statistical difference among curves. At univariate analysis GS, pTNM, and positive margins resulted to be significant predictors of BCR, while M1 and M2 did not achieve the statistical significance. At multivariate analysis, only GS and pathologic stage were independent predictors of BR. CONCLUSION: In our study patients with higher density of M count were associated with poor prognosis; M2 phenotype was significantly associated with ECE.


Subject(s)
Macrophages/metabolism , Prognosis , Prostatic Neoplasms/metabolism , Aged , Biopsy , Disease-Free Survival , Humans , Macrophages/pathology , Male , Middle Aged , Neoplasm Staging , Prostatectomy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery
3.
Oncogene ; 33(19): 2423-31, 2014 May 08.
Article in English | MEDLINE | ID: mdl-23728338

ABSTRACT

Inflammation is now acknowledged as an hallmark of cancer. Cancer-associated fibroblasts (CAFs) force a malignant cross talk with cancer cells, culminating in their epithelial-mesenchymal transition and achievement of stemness traits. Herein, we demonstrate that stromal tumor-associated cells cooperate to favor malignancy of prostate carcinoma (PCa). Indeed, prostate CAFs are active factors of monocyte recruitment toward tumor cells, mainly acting through stromal-derived growth factor-1 delivery and promote their trans-differentiation toward the M2 macrophage phenotype. The relationship between M2 macrophages and CAFs is reciprocal, as M2 macrophages are able to affect mesenchymal-mesenchymal transition of fibroblasts, leading to their enhanced reactivity. On the other side, PCa cells themselves participate in this cross talk through secretion of monocyte chemotactic protein-1, facilitating monocyte recruitment and again macrophage differentiation and M2 polarization. Finally, this complex interplay among cancer cells, CAFs and M2 macrophages, cooperates in increasing tumor cell motility, ultimately fostering cancer cells escaping from primary tumor and metastatic spread, as well as in activation of endothelial cells and their bone marrow-derived precursors to drive de novo angiogenesis. In keeping with our data obtained in vitro, the analysis of patients affected by prostate cancers at different clinical stages revealed a clear increase in the M2/M1 ratio in correlation with clinical values. These data, coupled with the role of CAFs in carcinoma malignancy to elicit expression of stem-like traits, should focus great interest for innovative strategies aimed at the co-targeting of inflammatory cells and fibroblasts to improve therapeutic efficacy.


Subject(s)
Adenocarcinoma/pathology , Cell Polarity , Fibroblasts/pathology , Macrophages/pathology , Prostatic Neoplasms/pathology , Adenocarcinoma/metabolism , Blotting, Western , Cell Differentiation , Cell Line, Tumor , Cell Movement , Disease Progression , Enzyme-Linked Immunosorbent Assay , Epithelial-Mesenchymal Transition/physiology , Fibroblasts/metabolism , Humans , Immunohistochemistry , Macrophages/metabolism , Male , Prostatic Neoplasms/metabolism , Receptor Cross-Talk/physiology , Tumor Microenvironment/physiology
4.
Cell Biochem Funct ; 14(2): 105-10, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8640950

ABSTRACT

The aim of our study was to evaluate the levels of fibronectin (FN) and its classic receptor (FNR) in various transformed cells lines, especially of leukemic origin, and also the influence of HIV-1 replication on the expression of these proteins (in particular on H9-V cells, chronically infected with HIV-1, and acutely infected MT-4 cells). Monoclonal antibodies were used for indirect immunofluorescence tests; the fluorescein-conjugated recombinant p14, the product of the HIV gene tat, was used as a molecular probe. The results demonstrated a high variability of FN and FNR expression among the various cellular lines studied. Moreover, deficits of such adhesive proteins did not necessarily correlate with a severe reduction of the corresponding receptor. HIV-1 replication in MT-4 and H9-V cells increased the expression of FNR. This seems to correlate with p14-induced phenomena because pretreatment of H9-V cells with recombinant p14 showed an enhancing effect on the expression of this receptor.


Subject(s)
Fibronectins/biosynthesis , HIV-1/metabolism , Receptors, Fibronectin/biosynthesis , Amnion/cytology , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , B-Lymphocytes/virology , Fluorescent Antibody Technique, Indirect , HIV Infections/metabolism , Humans , Leukemia, Lymphoid , Leukemia, Myeloid , Lymphoma , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , T-Lymphocytes/virology , Tumor Cells, Cultured/chemistry , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/virology , Urinary Bladder Neoplasms
5.
Cell Biochem Funct ; 14(1): 63-8, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8907256

ABSTRACT

We performed some in vitro tests for the detection of the immune state and compared the results. In particular we studied the production of various cytokines obtained by stimulating peripheral blood mononucleated cells (PBMC) with different inducers, using optimal and suboptimal doses. This was compared with the results of blastic transformation of lymphocytes, and with the evaluation of the capping effect of macrophages, and of the Multitest Merieux. The correlation between the different investigations was generally good. This permits a simplification of the study of immune reactivity, selecting some of the tests proposed. The use of suboptimal doses of inducers improves the evaluation of very moderate deficits and supplies an in vitro model for the study of immunomodulant drugs.


Subject(s)
Immunocompetence/drug effects , Adult , Cytokines/biosynthesis , Dose-Response Relationship, Immunologic , Evaluation Studies as Topic , Humans , Lectins/pharmacology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Lymphocyte Activation/drug effects , Mitogens/pharmacology , Reproducibility of Results
6.
J Chemother ; 7(1): 33-7, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7629556

ABSTRACT

In this study we reported about the antiviral activity of Aspergillus terreus alcohol extract against Herpes simplex type 1 virus. This activity is dose-dependent, is related to the concentration of the challenging virus and depends particularly on a proteic fraction of 5-10 Kda. Optimal effects were observed with doses ranging from 25 to 6.25 micrograms/ml for crude alcohol extract and up to 3 micrograms/ml for 5-10 Kda fraction. Moreover, antiviral activity was evident in viral replication, but not on virus out of the cells. An increased 3H thymidine incorporation was noted on infected cells treated with the extract and this effect may suggest an intracellular accumulation of viral DNA in the absence or reduction of virion production.


Subject(s)
Antiviral Agents/pharmacology , Aspergillus/chemistry , Biological Factors/pharmacology , Herpesvirus 1, Human/drug effects , Biological Factors/isolation & purification , Dose-Response Relationship, Drug , Herpesvirus 1, Human/physiology , Humans , Microbial Sensitivity Tests , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...